| PNS |
-
1.
Wallerian degeneration of the distal part of the axon resulting in fragmentation and disintegration of the axon in the first 18–48 h.
-
2.
Proinflammatory cytokines secretion: tumor necrosis factor-alpha (TNF-α) and interleukin-1-alpha (IL-1α).
-
3.
Removal of axonal and myelin debris by macrophages and SC.
-
4.
Interleukin-1 (IL-1) and platelet-derived growth factor stimulates SC to divide, de-differentiate, and proliferate distal to the injury.
-
5.
Stimulated SC to secrete growth factors such as nerve growth factor or insulin-like growth factor-1.
-
6.
Band Büngner formation guiding axon and growth cones to reconnect from proximal end to distal end across the gap.
|
|
[8,44] |
| CNS |
-
1.
Wallerian degeneration in the damaged tracts.
-
2.
Degeneration of myelin and axonal debris after the apoptosis of oligodendrocytes.
-
3.
Inhibitory neurite growth molecules in myelin: Nogo-A, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein.
-
4.
Glial scar formation is initiated by astrocytes with inhibitory molecules such as proteoglycans.
|
-
1.
Modulation of inhibitory microenvironment for axonal regeneration in the lesion site.
-
2.
Collaborative participation of distinct cell types for ideal axonal regeneration.
-
3.
Aligned distribution of neuronal cells to form orientational nerve bundles.
-
4.
Speeded reinnervation time being the most important determinant of successful clinical outcomes.
|
[45,46] |